APA (7th ed.) Citation

Hermanns‐Clausen, M., Sommer, M., Zschiesche, A., Angerer, V., Scheu, M., Eyer, F., . . . Auwärter, V. (2026). Acute toxicity of ADB‐CHMINACA ‐ a case series of patients with pronounced central nervous symptoms including the posterior reversible encephalopathic syndrome. British Journal of Clinical Pharmacology, 1. https://doi.org/10.1002/bcp.70538

Chicago Style (17th ed.) Citation

Hermanns‐Clausen, Maren, Michaela Sommer, Annette Zschiesche, Verena Angerer, Martin Scheu, Florian Eyer, Johannes Nadler, and Volker Auwärter. "Acute Toxicity of ADB‐CHMINACA ‐ a Case Series of Patients with Pronounced Central Nervous Symptoms Including the Posterior Reversible Encephalopathic Syndrome." British Journal of Clinical Pharmacology 2026: 1. https://doi.org/10.1002/bcp.70538.

MLA (9th ed.) Citation

Hermanns‐Clausen, Maren, et al. "Acute Toxicity of ADB‐CHMINACA ‐ a Case Series of Patients with Pronounced Central Nervous Symptoms Including the Posterior Reversible Encephalopathic Syndrome." British Journal of Clinical Pharmacology, 2026, p. 1, https://doi.org/10.1002/bcp.70538.